XML 49 R35.htm IDEA: XBRL DOCUMENT
v3.22.4

Note 14 - Parent Company Financial Statements (Unaudited) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Notes Tables |
Condensed Balance Sheet [Table Text Block] |
|  | 2022 |  |  | 2021 |
Assets |  |  |  |  |  |  |  |
Current assets |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 286 |  |  | $ | - |
Receivables due from subsidiaries |  |  | 98,780 |  |  |  | 93,571 |
Prepaid expenses |  |  | 611 |  |  |  | 290 |
Other current assets |  |  | 7 |  |  |  | 116 |
Total current assets |  |  | 99,684 |  |  |  | 93,977 |
Investment in Aemetis Property Keyes, Inc. |  |  | 1,274 |  |  |  | 496 |
Investment in Aemetis International, Inc. |  |  | 6,659 |  |  |  | 2,546 |
Investment in Aemetis Advanced Products Riverbank, Inc. |  |  | 173 |  |  |  | 23 |
Investment in Aemetis Carbon Capture, Inc. |  |  | - |  |  |  | 54 |
Total investments in Subsidiaries, net of advances |  |  | 8,106 |  |  |  | 3,119 |
Property, plant and equipment, net |  |  | 135 |  |  |  | 36 |
Other assets |  |  | 2,377 |  |  |  | 2,475 |
Total Assets |  | $ | 110,302 |  |  | $ | 99,607 |
Liabilities & stockholders' deficit |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |
Accounts payable |  | $ | 2,934 |  |  | $ | 3,024 |
Mandatorily redeemable Series B convertible preferred |  |  | 4,082 |  |  |  | 3,806 |
Other current liabilities |  |  | 4,269 |  |  |  | 9,521 |
Total current liabilities |  |  | 11,285 |  |  |  | 16,351 |
Long term liabilities: |  |  |  |  |  |  |  |
Operating lease liability |  |  | 2,047 |  |  |  | 2,318 |
Subsidiary obligation in excess of investment |  |  |  |  |  |  |  |
Investment in AE Advanced Fuels, Inc. |  |  | 177,856 |  |  |  | 150,424 |
Investment in Aemetis Americas, Inc |  |  | 205 |  |  |  | 205 |
Investment in Aemetis Biofuels, Inc. |  |  | 2,738 |  |  |  | 2,738 |
Investment in Aemetis Technologies, Inc. |  |  | 4,716 |  |  |  | 4,536 |
Investment in AE Advanced Products Keyes , Inc. |  |  | 270 |  |  |  | 383 |
Investment in Aemetis Health Products, Inc. |  |  | 2,076 |  |  |  | 2,137 |
Investment in Goodland Advanced Fuels, Inc. |  |  | 16,869 |  |  |  | 13,587 |
Investment in Aemetis Biogas LLC |  |  | 91,292 |  |  |  | 27,166 |
Investment in Aemetis Carbon Capture Inc |  |  | 2,323 |  |  |  | - |
Investment in Aemetis Properties Riverbank, Inc. |  |  | 479 |  |  |  | - |
Total subsidiary obligation in excess of investment |  |  | 298,824 |  |  |  | 201,176 |
Total long term liabilities |  |  | 300,871 |  |  |  | 203,494 |
Stockholders' deficit |  |  |  |  |  |  |  |
Series B Preferred convertible stock |  |  | 1 |  |  |  | 1 |
Common stock |  |  | 36 |  |  |  | 33 |
Additional paid-in capital |  |  | 232,546 |  |  |  | 205,305 |
Accumulated deficit |  |  | (428,985 | ) |  |  | (321,227 | )
Accumulated other comprehensive loss |  |  | (5,452 | ) |  |  | (4,350 | )
Total stockholders' deficit |  |  | (201,854 | ) |  |  | (120,238 | )
Total liabilities & stockholders' deficit |  | $ | 110,302 |  |  | $ | 99,607 |
Condensed Income Statement [Table Text Block] |
|  | 2022 |  |  | 2021 |
Equity in subsidiary losses |  | $ | (91,561 | ) |  | $ | (34,400 | )
Selling, general and administrative expenses |  |  | 15,203 |  |  |  | 11,806 |
Operating loss |  |  | (106,764 | ) |  |  | (46,206 | )
Other (income) expense |  |  |  |  |  |  |  |
Interest expense |  |  | 806 |  |  |  | 1,031 |
Debt related fees and amortization expense |  |  | 1,581 |  |  |  | - |
Other income |  |  | (1,400 | ) |  |  | (97 | )
Loss before income taxes |  |  | (107,751 | ) |  |  | (47,140 | )
Income tax expense |  |  | 7 |  |  |  | 7 |
Net loss |  |  | (107,758 | ) |  |  | (47,147 | )
Other comprehensive loss |  |  |  |  |  |  |  |
Foreign currency translation adjustment |  |  | (1,102 | ) |  |  | (27 | )
Comprehensive loss |  | $ | (108,860 | ) |  | $ | (47,174 | )
Condensed Cash Flow Statement [Table Text Block] |
|  | 2022 |  |  | 2021 |
Operating activities: |  |  |  |  |  |  |  |
Net loss |  |  | (107,758 | ) |  |  | (47,147 | )
Adjustments to reconcile net loss to net cash used in operating activities: |  |  |  |  |  |  |  |
Stock-based compensation |  |  | 6,410 |  |  |  | 3,928 |
Depreciation |  |  | 29 |  |  |  | 8 |
Debt related fees and amortization expense |  |  | 1,776 |  |  |  | - |
Subsidiary portion of net losses |  |  | 91,561 |  |  |  | 34,400 |
Gain on debt extinguishment |  |  | - |  |  |  | (421 | )
Gain on litigation |  |  | (1,400 | ) |  |  | - |
Changes in assets and liabilities: |  |  |  |  |  |  |  |
Prepaid expenses |  |  | 111 |  |  |  | (38 | )
Accounts payable |  |  | (90 | ) |  |  | (1,043 | )
Accrued interest expense |  |  | 778 |  |  |  | 998 |
Other liabilities |  |  | (4,625 | ) |  |  | (902 | )
Other assets |  |  | 207 |  |  |  | 109 |
Net cash used in operating activities |  |  | (13,001 | ) |  |  | (10,108 | )
Investing activities: |  |  |  |  |  |  |  |
Capital expenditures |  |  | (128 | ) |  |  | - |
Subsidiary advances, net |  |  | 1,222 |  |  |  | (95,105 | )
Net cash provided by (used in) investing activities |  |  | 1,094 |  |  |  | (95,105 | )
Financing activities: |  |  |  |  |  |  |  |
Proceeds from the exercise of stock options |  |  | 206 |  |  |  | 1,304 |
Proceeds from issuance of common stock in equity offering |  |  | 11,987 |  |  |  | 103,591 |
Net cash provided by financing activities |  |  | 12,193 |  |  |  | 104,895 |
Net increase in cash, cash equivalents, and restricted cash |  |  | 286 |  |  |  | (318 | )
Cash, cash equivalents and restricted cash at beginning of period |  |  | - |  |  |  | 318 |
Cash, cash equivalents, and restricted cash at end of period |  | $ | 286 |  |  | $ | - |
Supplemental disclosures of cash flow information, cash paid: |  |  |  |  |  |  |  |
Income taxes paid |  |  | 7 |  |  |  | 7 |
Supplemental disclosures of cash flow information, non-cash transactions: |  |  |  |  |  |  |  |
Fair value of warrants issued to subordinated debt holders |  |  | 1,939 |  |  |  | 1,546 |
Fair value of stock issued to a related party for guarantee fees |  |  | 2,012 |  |  |  | - |
Fair value of warrants issued for capital expenditures |  |  | - |  |  |  | 1,344 |
Fair value of warrants issued to lender for debt issuance costs |  |  | 3,158 |  |  |  | - |
Fair value of stock issued to lender |  |  | 1,335 |  |  |  | - |
Issuance of equity to pay off accounts payable |  |  | - |  |  |  | 893 |

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 12 -Paragraph (a) -Subsection 04 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 12 -Paragraph (a) -Subsection 04 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690 + Details
Name: | srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 12 -Paragraph (a) -Subsection 04 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration